These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15880397)

  • 1. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.
    Kim H; McGrath BM; Silverstone PH
    Hum Psychopharmacol; 2005 Jul; 20(5):309-26. PubMed ID: 15880397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.
    Silverstone PH; McGrath BM; Kim H
    Bipolar Disord; 2005 Feb; 7(1):1-10. PubMed ID: 15654927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    McGrath BM; McKay R; Dave S; Seres P; Weljie AM; Slupsky CM; Hanstock CC; Greenshaw AJ; Silverstone PH
    Neurosci Res; 2008 Aug; 61(4):351-9. PubMed ID: 18508145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients.
    Silverstone PH; McGrath BM
    Int Rev Psychiatry; 2009; 21(4):414-23. PubMed ID: 20374155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic dysfunction of the serotonin receptor 5-HT2A in psychiatric disorders].
    Arranz B; Rosel P; Ramírez N; San L
    Actas Esp Psiquiatr; 2001; 29(2):131-8. PubMed ID: 11333532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research.
    Stork C; Renshaw PF
    Mol Psychiatry; 2005 Oct; 10(10):900-19. PubMed ID: 16027739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study.
    Silverstone PH; O'Donnell T; Ulrich M; Asghar S; Hanstock CC
    Hum Psychopharmacol; 2002 Dec; 17(8):425-9. PubMed ID: 12457379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lithium does not alter human myo-inositol or phosphomonoester concentrations as measured by 1H and 31P MRS.
    Silverstone PH; Hanstock CC; Fabian J; Staab R; Allen PS
    Biol Psychiatry; 1996 Aug; 40(4):235-46. PubMed ID: 8871769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased prefrontal Myo-inositol in major depressive disorder.
    Coupland NJ; Ogilvie CJ; Hegadoren KM; Seres P; Hanstock CC; Allen PS
    Biol Psychiatry; 2005 Jun; 57(12):1526-34. PubMed ID: 15953489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry.
    Pacchierotti C; Iapichino S; Bossini L; Pieraccini F; Castrogiovanni P
    Front Neuroendocrinol; 2001 Jan; 22(1):18-32. PubMed ID: 11141317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders.
    Shih RA; Belmonte PL; Zandi PP
    Int Rev Psychiatry; 2004 Nov; 16(4):260-83. PubMed ID: 16194760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders.
    Moore GJ; Galloway MP
    Psychopharmacol Bull; 2002; 36(2):5-23. PubMed ID: 12397837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.
    Mason GF; Krystal JH
    NMR Biomed; 2006 Oct; 19(6):690-701. PubMed ID: 16986118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T.
    McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
    Neuroreport; 2006 Aug; 17(12):1323-6. PubMed ID: 16951578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton spectroscopy study of the left dorsolateral prefrontal cortex in pediatric depressed patients.
    Caetano SC; Fonseca M; Olvera RL; Nicoletti M; Hatch JP; Stanley JA; Hunter K; Lafer B; Pliszka SR; Soares JC
    Neurosci Lett; 2005 Aug; 384(3):321-6. PubMed ID: 15936878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.
    Lan MJ; McLoughlin GA; Griffin JL; Tsang TM; Huang JT; Yuan P; Manji H; Holmes E; Bahn S
    Mol Psychiatry; 2009 Mar; 14(3):269-79. PubMed ID: 18256615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.